A prospective study on the prevalence of MASLD in people with type‐2 diabetes in the community. Cost effectiveness of screening strategies

AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease

(2023) Mary E. Rinella et al.   HEPATOLOGY

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review

(2023) Zobair M. Younossi et al.   HEPATOLOGY

Non-alcoholic fatty liver disease in women – Current knowledge and emerging concepts

(2023) Pei Chia Eng et al.   JHEP Reports

Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications

(2022) Jérôme Boursier et al.   Clinical Gastroenterology and Hepatology

Impact of non-invasive biomarkers on hepatology practice: Past, present and future

(2022) Quentin M. Anstee et al.   JOURNAL OF HEPATOLOGY

Head to head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD

(2022) Beom Kyung Kim et al.   JOURNAL OF HEPATOLOGY

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2023

(2022) Nuha A. ElSayed et al.   DIABETES CARE

A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes

(2022) Veeral Ajmera et al.   JOURNAL OF HEPATOLOGY

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update

(2021) Annalisa Berzigotti et al.   JOURNAL OF HEPATOLOGY

Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis

(2021) Alessandro Mantovani et al.   Lancet Gastroenterology & Hepatology

Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population

(2021) Isabel Graupera et al.   Clinical Gastroenterology and Hepatology

2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis

(2021) Michael H. Le et al.   Clinical Gastroenterology and Hepatology

Advancing the global public health agenda for NAFLD: a consensus statement

(2021) Jeffrey V. Lazarus et al.   Nature Reviews Gastroenterology & Hepatology

Low Screening Rates Despite a High Prevalence of Significant Liver Fibrosis in People with Diabetes from Primary and Secondary Care

(2021) Laurence J. Dobbie et al.   Journal of Clinical Medicine

Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter?

(2021) Roberta Forlano et al.   World Journal of Hepatology

The association between education level and chronic liver disease of any etiology

(2020) Tommaso Stroffolini et al.   European Journal of Internal Medicine

Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of Nonalcoholic Fatty Liver Disease

(2020) James M. Paik et al.   HEPATOLOGY

Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies

(2020) Helen Jarvis et al.   PLOS MEDICINE

Screening for Non-Alcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the U.S. is Cost Effective: A Comprehensive Cost-Utility Analysis

(2020) Mazen Noureddin et al.   GASTROENTEROLOGY

Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis

(2020) Guillaume Lassailly et al.   GASTROENTEROLOGY

Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals

(2020) Alessandro Mantovani et al.   GUT

Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease

(2019) Ankur Srivastava et al.   BMC GASTROENTEROLOGY

Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia

(2019) Miquel Serra-Burriel et al.   JOURNAL OF HEPATOLOGY

Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Non‐alcoholic Fatty Liver Disease

(2019) Fasiha Kanwal et al.   HEPATOLOGY

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD

(2017) Hannes Hagström et al.   JOURNAL OF HEPATOLOGY

Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study

(2017) Lukasz Tanajewski et al.   BMJ Open

Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children

(2016) David E. Kleiner et al.   Clinics in Liver Disease

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score

(2016) Elliot B. Tapper et al.   PLoS One

Nonalcoholic Fatty Liver Disease is Underrecognized in the Primary Care Setting

(2014) Pierre Blais et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis

(2014) Roger Williams et al.   LANCET